Product Program year 2023 Source: CMS Open Payments

Aprocitentan

Open in the dashboard

General payments

$77,374

76 payments

Research payments

$0

0 payments

Through program year 2023, $77,374 in general payments and $0 in research payments were reported against Aprocitentan.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2023 General $77,374 76

Breakdown

Who paid General payments · program year 2023
  1. Idorsia Pharmaceuticals US Inc $77,374 76 payments
Top recipients General payments · program year 2023
  1. Florian Rader Cardiovascular Disease · West Hollywood, CA $16,524 21% · 12 payments
  2. Michael Weber West Islip, NY $12,861 17% · 12 payments
  3. James Byrd Cardiovascular Disease · Ann Arbor, MI $11,060 14% · 11 payments
  4. Vivek Bhalla Nephrology · Stanford, CA $10,277 13% · 8 payments
  5. Michael Bloch Internal Medicine · Reno, NV $8,987 12% · 10 payments

The top 5 of 8 recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Cardiovascular Disease Internal Medicine $27,583 43% · 2 practitioners
  2. Internal Medicine $17,970 28% · 2 practitioners
  3. Nephrology Internal Medicine $16,499 26% · 2 practitioners
  4. Interventional Cardiology Internal Medicine $2,460 4% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2023
  1. California $26,801 35% · 2 recipients
  2. New York $15,321 20% · 2 recipients
  3. Michigan $11,060 14% · 1 recipient
  4. Nevada $8,987 12% · 1 recipient
  5. Illinois $8,983 12% · 1 recipient

The top 5 of 6 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

76 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record